Seneschal Advisors, LLC Novartis Ag Transaction History
Seneschal Advisors, LLC
- $138 Billion
- Q3 2025
A detailed history of Seneschal Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Seneschal Advisors, LLC holds 178 shares of NVS stock, worth $23,415. This represents 0.02% of its overall portfolio holdings.
Number of Shares
178Holding current value
$23,415% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding NVS
# of Institutions
1,601Shares Held
137MCall Options Held
1.44MPut Options Held
1.87M-
Dodge & Cox San Francisco, CA10.6MShares$1.39 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA9.34MShares$1.23 Billion0.95% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.84MShares$1.16 Billion0.25% of portfolio
-
Morgan Stanley New York, NY7.73MShares$1.02 Billion0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.24MShares$952 Million0.34% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...